Smart Sense Aspirin Recalled for Incorrect Expiration Date Labeling
AAA Pharmaceutical is recalling Smart Sense Regular Strength Aspirin Tablets due to an incorrect expiration date on the label.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The issue is a minor labeling error regarding the expiration date.
Plain-English summary
AAA Pharmaceutical, Inc. is recalling Smart Sense Regular Strength Aspirin Tablets, 325 mg, in 100-count and 500-count bottles. The product is distributed by Kmart Corporation. The recall involves 288 bottles of the 100-count size and 48 bottles of the 500-count size.
The recall is due to a labeling error where the product displays an incorrect expiration date of 9/2022, while the actual expiration date is 10/2021. The affected lots are P136370 and P136366. The distribution pattern is listed as KS.
Consumers who have purchased these specific bottles should check the expiration date and lot number. If the product matches the recalled description, consumers should stop using it and contact the distributor or retailer for a refund or replacement.
The recalled product
- Product
- Smart Sense Regular Strength Aspirin Tablets, 325 mg packed in a) 100 count UPC 8-8397-38781-6 and b) 500 count UPC 8-83967-38786-1 bottles, Distributed by: Kmart Corporation Hoffman Estates, IL 60179
- Manufacturer
- AAA Pharmaceutical, Inc.
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- a) P136370
- exp 9/2022 b) P136366
- exp 9/2022
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · AAA Pharmaceutical, Inc.
See all →- LowAAA Pharmaceutical Recalls Fexofenadine Tablets for Labeling Errors
FDA (Drugs) · 2020-03-11
- SevereAAA Pharmaceutical Recalls Ranitidine Tablets Due to NDMA Impurity
FDA (Drugs) · 2020-01-15
- SevereAAA Pharmaceutical Recalls Ranitidine Tablets Due to NDMA Impurity
FDA (Drugs) · 2020-01-15
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- SevereAcetaminophen tablets incorrectly labeled with aspirin drug facts information
FDA (Drugs) · 2024-08-14
- ModerateZEE Aspirin Recalled for Incorrect Inactive Ingredient Labeling
FDA (Drugs) · 2014-10-29
- LowAcetaminophen tablets recalled for incorrect imprinting
FDA (Drugs) · 2025-01-22
- ModerateAcetaminophen Extra Strength tablets recalled for incorrect product imprint identification
FDA (Drugs) · 2025-01-22
- ModerateAcetaminophen Extra Strength tablets recalled for incorrect imprinting
FDA (Drugs) · 2025-01-22
- SevereAmerican Family Pharmacy Recalls Subpotent Aspirin Tablets
FDA (Drugs) · 2014-10-29